TEM's Genomics unit is expected to report strong growth for the fourth quarter, banking on continued unit growth pick-up.

Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.

Analyst discusses AI stock Tempus AI, highlighting potential for profitability by 2025, insider selling, and sector risks.

Tempus AI's innovative products are transforming the healthcare industry, with a focus on oncology and large market ...

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look ...

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free ...

Tempus AI stock had its best day on record on Tuesday after the medical tech company launched an AI-powered health concierge ...

Tempus AI Inc (NASDAQ:TEM) shares are trading higher Wednesday. The stock appears to be moving on continued momentum from ...

Tempus AI Inc (TEM) stock saw a modest uptick, ending the day at $51.86 which represents a slight increase of $0.46 or 0.89% from the prior close of $51.4. The stock opened at $49.62 and touched a low ...

Tempus AI’s strategic moves and groundbreaking technological applications mark it as a key player in the future of precision ...

We recently published a list of 10 Must-Watch AI Stocks on Investors’ Radar. In this article, we are going to take a look at ...

In this article, we are going to take a look at where Tempus AI, Inc (NASDAQ:TEM) stands against other buzzing AI stocks on ...